The Impact of Chronic Endometritis on Infertility: Prevalence, Reproductive Outcomes, and the Role of Hysteroscopy as a Screening Tool
Gynecologic and Obstetric Investigation · 2023
DOI: 10.1159/000529304 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Gynecologic and Obstetric Investigation, 2023. Verfasst von Brecht Geysenbergh und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynaecology, UZ Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Endometritis, Hysteroscopy, Infertility, Female. Die Arbeit wurde bisher 11-mal zitiert (Crossref).
Abstract (Originalsprache)
Objectives
The objective of this study was to examine the prevalence of chronic endometritis (CE) in infertile women, its impact on reproductive outcomes, and the accuracy of hysteroscopy as a screening tool for CE.
Design
This was a prospective observational study.
Participants
Participants involved in this study were 514 asymptomatic patients with infertility.
Setting
The review was conducted in a tertiary care center.
Methods
The participants underwent a hysteroscopy and endometrial biopsy (EMB). Antibiotics were given for cases of CE. We investigated the prevalence of CE in patients starting assisted reproductive technologies (ART) as a primary outcome. Secondary outcomes were the clinical pregnancy rate (CPR) in the ART cycle after hysteroscopy, EMB, and antibiotic treatment in cases of CE; the cumulative CPR in the subsequent 2 years after hysteroscopy and EMB; the sensitivity and specificity of hysteroscopy as a screening tool compared to EMB as the “gold standard” for diagnosing CE.
Results
CE was identified in 2.8% of patients starting ART (11/393). CPRs did not differ significantly between patients with CE and the entire cohort of patients without CE in the subsequent ART cycle (OR: 0.43; 95% CI: 0.09–2.02) or in the 2 years after EMB (OR: 0.56; 95% CI: 0.16–1.97). In a matched control comparison (with matching for age, basal FSH, and cause of infertility), CPR in patients with CE did not differ in the subsequent ART cycle (OR: 0.39; 95% CI: 0.09–1.61); however, their CPR in the 2 years after EMB was significantly lower (OR: 0.22; 95% CI: 0.13–0.38). The sensitivity and specificity of hysteroscopy as a screening tool for diagnosing CE were 8.3% and 90.1%, respectively.
Limitations
Due to our cohort’s low CE prevalence, we could not detect significant differences in CPRs.
Conclusion
CE is rare in our studied population of asymptomatic patients starting ART. Hysteroscopy cannot replace EMB for diagnosing CE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynaecology, UZ Leuven, Leuven, Belgium.
- Department of Gynaecology, GZA Hospitals, Antwerp, Belgium.
- Department of Gynaecology, AZ Diest, Diest, Belgium.
- Department of Pathology, UZ Leuven, Leuven, Belgium.
- Department of Gynaecology, Jessa Hospital, Hasselt, Belgium.
- Department of Development and Regeneration, KULeuven, Leuven, Belgium.
Zitieren
APA
Geysenbergh, B., Boes, A. S., Bafort, C., Van Rompuy, A. S., Neyens, S., Lie-Fong, S., Debrock, S., Vriens, J., De Loecker, P., Dancet, E., D'Hooghe, T., & Peeraer, K. (2023). The Impact of Chronic Endometritis on Infertility: Prevalence, Reproductive Outcomes, and the Role of Hysteroscopy as a Screening Tool. Gynecologic and Obstetric Investigation. https://doi.org/10.1159/000529304
Vancouver
Geysenbergh B, Boes AS, Bafort C, Van Rompuy AS, Neyens S, Lie-Fong S, et al. The Impact of Chronic Endometritis on Infertility: Prevalence, Reproductive Outcomes, and the Role of Hysteroscopy as a Screening Tool. Gynecologic and Obstetric Investigation. 2023. doi:10.1159/000529304
BibTeX
@article{Geysenbergh2023,
author = {Geysenbergh, Brecht and Boes, Anne-Sophie and Bafort, Céline and Van Rompuy, Anne-Sophie and Neyens, Sara and Lie-Fong, Sharon and Debrock, Sophie and Vriens, Joris and De Loecker, Peter and Dancet, Eline and D'Hooghe, Thomas and Peeraer, Karen},
title = {The Impact of Chronic Endometritis on Infertility: Prevalence, Reproductive Outcomes, and the Role of Hysteroscopy as a Screening Tool},
journal = {Gynecologic and Obstetric Investigation},
year = {2023},
doi = {10.1159/000529304}
}
EUVIMED